Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Topical IKKα inhibitors may help prevent CCS tumours.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.